Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia

Bibliographic Details
Main Authors:	Mei‐Jing Liu, Kai‐Wen Tan, Han‐Yu Cao, Si‐Man Huang, Chong‐Sheng Qian, Sheng‐Li Xue, Hai‐Ping Dai, Wen‐Jie Gong
Format:	Article
Language:	English
Published:	Wiley 2024-02-01
Series:	HemaSphere
Online Access:	https://doi.org/10.1002/hem3.49

Internet

https://doi.org/10.1002/hem3.49